Quotient Sciences

Quotient Sciences company information, Employees & Contact Information

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. We employ over 1,300+ staff and operate from state-of-the-art manufacturing and clinical facilities in the US and UK. Our people make Quotient Sciences a special place to work. We are a dedicated team passionate about innovating and transforming drug development to help our customers develop new medicines for patients in need. We recruit people that are committed to making a difference, who excel at customer service and are always willing to go the extra mile. Teamwork is integral to our culture and success — helping, supporting and mentoring run through our DNA. Expect to join an empowering and innovative culture, where we encourage continuous improvement and offer opportunities to learn and develop every day.
Looking for a particular Quotient Sciences employee's phone or email?

Quotient Sciences Questions

News

Quotient Sciences and CPI to Accelerate RNA Drug Development with Joint Venture - PR Newswire

Quotient Sciences and CPI to Accelerate RNA Drug Development with Joint Venture PR Newswire

Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept - PR Newswire UK

Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept PR Newswire UK

Seminar: From Bench to Bedside: Accelerating Early Drug Development with an Integrated, Multi-Phase Development Partner - mva.org

Seminar: From Bench to Bedside: Accelerating Early Drug Development with an Integrated, Multi-Phase Development Partner mva.org

Fortifying pharmaceutical innovation, from laboratory to clinic - The Independent

Fortifying pharmaceutical innovation, from laboratory to clinic The Independent

Nanomerics Reports First Volunteers Dosed in the OC134 SUNLIGHT Trial - ACCESS Newswire

Nanomerics Reports First Volunteers Dosed in the OC134 SUNLIGHT Trial ACCESS Newswire

Quotient's streamlined drug development process saves months - Pharmaceutical Technology

Quotient's streamlined drug development process saves months Pharmaceutical Technology

Partnership Series | Quotient Sciences - Permira

Partnership Series | Quotient Sciences Permira

Quotient integrates drug substance synthesis and manufacturing - Pharmaceutical Technology

Quotient integrates drug substance synthesis and manufacturing Pharmaceutical Technology

Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization - Business Wire

Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization Business Wire

Anle138b to target the toxic protein in Parkinson’s - Cure Parkinson's

Anle138b to target the toxic protein in Parkinson’s Cure Parkinson's

Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic - Pharmaceutical Technology

Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic Pharmaceutical Technology

Top Quotient Sciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant